Patent · US Active

Ketoamide compound and preparation method, pharmaceutical composition, and use thereof

US12152017B2 · kind B2 · utility

0Cited by
0References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 9, 2019
Grant dateNov 26, 2024
Priority date
Expiry dateMar 21, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A ketoamide compound and a preparation method, a pharmaceutical composition, and a use thereof. Specifically, the ketoamide compound shown in formula (A), a racemate, an enantiomer, or a diastereoisomer thereof, or any mixture of same, or a pharmaceutically active metabolite thereof, or a pharmaceutically acceptable salt, solvate, or prodrug thereof. The ketoamide compound can effectively inhibit coronavirus or Ebola virus, and thereby implement the prevention or treatment of diseases related to coronavirus or diseases related to Ebola virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.